10X Genomics Inc (TXG) — Tangible Net Worth Ratio
10X Genomics Inc (TXG) has a Tangible Net Worth Ratio of 91.8% as of September 2025. This metric is calculated by deducting intangible assets ($64.76 Million) from net assets ($786.33 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See TXG book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
10X Genomics Inc Tangible Net Worth Ratio (2019–2024)
This chart shows how 10X Genomics Inc's Tangible Net Worth Ratio has changed across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 91.8%, reflecting net assets of $786.33 Million with intangible assets of $64.76 Million USD. Also explore TXG year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for 10X Genomics Inc (2019–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for 10X Genomics Inc from 2019 to 2024, covering 6 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see TXG company net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.8% | $710.13 Million | $15.67 Million | $918.64 Million | ▲ +0.0 pp |
| 2023 | 97.8% | $741.04 Million | $16.62 Million | $965.14 Million | ▲ +0.6 pp |
| 2022 | 97.2% | $805.74 Million | $22.86 Million | $1.03 Billion | ▲ +0.3 pp |
| 2021 | 96.9% | $817.57 Million | $25.40 Million | $1.02 Billion | ▼ -0.1 pp |
| 2020 | 97.0% | $739.07 Million | $22.35 Million | $929.34 Million | ▼ -2.9 pp |
| 2019 | 99.9% | $420.08 Million | $400.00K | $605.92 Million | — |